DEUTSCHE BANK AG\ - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 23 filers reported holding ADMA BIOLOGICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q2 2024$34,033,876
+68.9%
3,044,175
-0.3%
0.02%
+66.7%
Q1 2024$20,146,130
+45.9%
3,052,444
-0.1%
0.01%
+28.6%
Q4 2023$13,810,028
+3474.0%
3,055,316
+2730.7%
0.01%
Q3 2023$386,404
+25.8%
107,934
+29.7%
0.00%
Q2 2023$307,148
-29.5%
83,238
-36.8%
0.00%
Q1 2023$435,781
-34.8%
131,656
-23.6%
0.00%
Q4 2022$668,334
+68.3%
172,251
+5.5%
0.00%
Q3 2022$397,000
+14.1%
163,341
-7.1%
0.00%
Q2 2022$348,000
+123.1%
175,760
+105.8%
0.00%
Q1 2022$156,000
+30.0%
85,4000.0%0.00%
Q4 2021$120,000
+23.7%
85,4000.0%0.00%
Q3 2021$97,000
-29.2%
85,4000.0%0.00%
Q2 2021$137,000
-39.6%
85,400
-33.9%
0.00%
Q1 2021$227,000
-11.0%
129,244
-1.0%
0.00%
Q4 2020$255,000
-40.3%
130,493
-26.9%
0.00%
Q3 2020$427,000
-63.8%
178,538
-55.7%
0.00%
-100.0%
Q2 2020$1,181,000
+272.6%
403,179
+266.6%
0.00%
Q1 2020$317,000
-24.0%
109,983
+5.3%
0.00%
Q4 2019$417,000
-6.9%
104,491
+3.4%
0.00%
Q3 2019$448,000
+222.3%
101,050
+179.4%
0.00%
Q2 2019$139,000
+52.7%
36,171
+48.9%
0.00%
Q1 2019$91,000
+54.2%
24,286
-3.4%
0.00%
Q4 2018$59,000
-95.6%
25,131
-88.4%
0.00%
Q3 2018$1,346,000
+351.7%
216,922
+226.4%
0.00%
Q2 2018$298,000
+1003.7%
66,457
+1318.8%
0.00%
Q2 2016$27,000
-18.2%
4,684
+11.5%
0.00%
Q1 2016$33,000
+200.0%
4,200
+250.0%
0.00%
Q2 2015$11,0001,2000.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Prosight Management, LP 883,214$1,722,0000.80%
Telemetry Investments, L.L.C. 200,615$391,0000.66%
Perceptive Advisors 16,584,802$32,340,0000.35%
Consonance Capital Management LP 1,558,290$3,039,0000.28%
683 Capital Management, LLC 2,000,000$3,900,0000.18%
ESSEX INVESTMENT MANAGEMENT CO LLC 627,931$1,224,0000.15%
GSA CAPITAL PARTNERS LLP 327,052$638,0000.10%
APOGEM CAPITAL LLC 54,240$106,0000.07%
HUSSMAN STRATEGIC ADVISORS, INC. 82,000$160,0000.04%
J. Goldman & Co LP 376,319$734,0000.04%
View complete list of ADMA BIOLOGICS INC shareholders